The nation of Zimbabwe has declined a substantial American healthcare agreement worth 367 million US dollars (£272m) spanning five years due to Washington's insistence on sensitive information.
This move became public following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
An official spokesperson later clarified that the United States was seeking health data for research and commercial gain while refused to share the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for further dialogue to reach a agreement agreeable to all parties so the nation's critical HIV treatment initiative can proceed.
Wider Background
This rejection comes after a comparable situation in Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the security of Kenyans' health data.
After resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had administered aid for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance openness and accountability.
According to reports, 16 nations in Africa have so far signed similar agreements, constituting more than $18.3bn in new funding.
Details of the Declined Deal
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy through American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Effectively, our nation would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be available to our citizens if a future disease outbreak arise."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks previously established through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.
"This mechanism is designed to guarantee that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
These objections over the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to further discussions with our American counterparts on how subsequent collaboration might be structured in a way that respects the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that talks need to persist considering a large portion of the nation's Aids initiatives relied on external financing.
"In cases where specific concerns exist, including those involving information security or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," the group added.
This impasse underscores the continuing tensions between receiving much-needed foreign assistance and protecting a country's data in an ever more data-driven world.